Literature DB >> 22956075

[Recommendations for death rattle].

T Pastrana1, H Reineke-Bracke, F Elsner.   

Abstract

Noisy breathing during the terminal stages of life (death rattle) is one of the most common and most difficult symptoms to treat. In palliative medicine there are still no accepted guidelines for the treatment of death rattle in the final phase of life. In the first part of this article a description of death rattle is presented and in the second part a systematic literature review gives an insight into the effectiveness of interventions for death rattle. Two databases (Embase and Medline) were searched up to 2010 which identified 134 studies but only 6 met the inclusion criteria (2 cohort and 4 experimental studies) in which scopolamine, glycopyrrolate, butyl scopolamine, atropine and octreotide were tested. There is a lack of conclusive studies which investigated the effectiveness of treatment of death rattle. Furthermore, the identified studies revealed methodical problems. In general non-drug therapy is recommended as first choice. If anticholinergics are considered the selection also depends on whether simultaneous sedation is desired or not. The English full text version of this article will be available in SpringerLink as of November 2012 (under "Supplemental").

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956075     DOI: 10.1007/s00482-012-1215-8

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  33 in total

1.  A comparison of plasma levels of hyoscine after oral and transdermal administration.

Authors:  C Muir; R Metcalfe
Journal:  J Pharm Biomed Anal       Date:  1983       Impact factor: 3.935

2.  [The PRISMA Statement - what should be reported about systematic reviews?].

Authors:  Gerd Antes; E von Elm
Journal:  Dtsch Med Wochenschr       Date:  2009-07-31       Impact factor: 0.628

3.  Risk factors for death rattle in terminally ill cancer patients: a prospective exploratory study.

Authors:  T Morita; J Tsunoda; S Inoue; S Chihara
Journal:  Palliat Med       Date:  2000-01       Impact factor: 4.762

4.  The last 48 hours of life.

Authors:  I Lichter; E Hunt
Journal:  J Palliat Care       Date:  1990       Impact factor: 2.250

5.  A prospective study on the dying process in terminally ill cancer patients.

Authors:  T Morita; T Ichiki; J Tsunoda; S Inoue; S Chihara
Journal:  Am J Hosp Palliat Care       Date:  1998 Jul-Aug       Impact factor: 2.500

6.  A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle.

Authors:  I N Back; K Jenkins; A Blower; J Beckhelling
Journal:  Palliat Med       Date:  2001-07       Impact factor: 4.762

7.  [Efficacy of glycopyrronium bromide and scopolamine hydrobromide in patients with death rattle: a randomized controlled study].

Authors:  Rudolf Likar; Ernst Rupacher; Hans Kager; Mario Molnar; Wofgang Pipam; Reinhard Sittl
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

8.  The sound of death rattle II: how do relatives interpret the sound?

Authors:  B L Wee; P G Coleman; R Hillier; S H Holgate
Journal:  Palliat Med       Date:  2006-04       Impact factor: 4.762

9.  The sound of death rattle I: are relatives distressed by hearing this sound?

Authors:  Bee L Wee; P G Coleman; R Hillier; S H Holgate
Journal:  Palliat Med       Date:  2006-04       Impact factor: 4.762

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  BMJ       Date:  2009-07-21
View more
  4 in total

1.  Clinical factors influencing death rattle breathing in palliative care cancer patients : Non-interventional study.

Authors:  Rudolf Likar; Manuela Christine Michenthaler; Romana Traar; Mario Molnar; Stefan Neuwersch
Journal:  Z Gerontol Geriatr       Date:  2016-05-31       Impact factor: 1.281

Review 2.  [Provision of palliative care for people with advanced dementia].

Authors:  J Diehl-Schmid; L Riedl; U Rüsing; J Hartmann; M Bertok; C Levin; J Hamann; M Arcand; S Lorenzl; B Feddersen; R J Jox
Journal:  Nervenarzt       Date:  2018-05       Impact factor: 1.214

Review 3.  [Interprofessional symptom management at the end of life].

Authors:  S Frankenhauser; M J P Geist; M A Weigand; H J Bardenheuer; J Keßler
Journal:  Anaesthesist       Date:  2017-11       Impact factor: 1.041

4.  [Interprofessional symptom management at the end of life].

Authors:  S Frankenhauser; M J P Geist; M A Weigand; H J Bardenheuer; J Keßler
Journal:  Urologe A       Date:  2018-05       Impact factor: 0.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.